Stage of diagnosis and survival for prostate cancer among immigrant men in Ontario, Canada
View abstract on PubMed
Summary
This summary is machine-generated.Prostate cancer patients who immigrated to Ontario, Canada, were more often diagnosed early and had better survival rates. Immigrants from the Caribbean and Sub-Saharan Africa showed the greatest benefits, while South Asian men had the least advantage.
Area Of Science
- Oncology
- Epidemiology
- Public Health
Background
- Previous studies identified higher prostate cancer incidence in West African and Caribbean immigrant groups in Ontario.
- This study investigates diagnostic stage and survival outcomes for prostate cancer among diverse immigrant populations in Ontario.
Purpose Of The Study
- To compare prostate cancer diagnosis stage, 5-year overall survival, and prostate cancer-specific survival between immigrants and long-term residents in Ontario.
- To identify specific immigrant groups with differential outcomes.
Main Methods
- Population-level retrospective cohort study using linked administrative databases in Ontario.
- Included male residents aged 20-105 with incident prostate cancer (March 2008-March 2017).
- Multivariable logistic regression and Kaplan-Meier curves were used to analyze diagnostic stage and survival, adjusting for covariates.
Main Results
- Immigrants from West Africa, East Africa, and the Caribbean had a higher likelihood of early-stage prostate cancer diagnosis compared to long-term residents.
- South Asian men were most likely to be diagnosed at a late stage.
- Overall and prostate cancer-specific survival rates were higher for immigrants than long-term residents, with Caribbean and Sub-Saharan African men showing the best survival, and South Asian men the lowest.
Conclusions
- Immigrant men in Ontario diagnosed with prostate cancer benefit from earlier diagnosis and improved 5-year survival compared to long-term residents.
- Significant variations exist among immigrant groups, with Caribbean and Sub-Saharan African men demonstrating superior outcomes.
- Potential contributing factors include awareness, diagnostic practices, genetics, and social determinants of health.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

